Skip to Main Content

Paper Details

Profiling the immune landscape in mucinous ovarian carcinoma.
Gynecol Oncol
6
2023
Author NameAffiliation
Jennifer AlsopUniversity of Cambridge
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge
Angela Brooks-Wilson
Derek S ChiuUniversity of British Columbia, and Vancouver General Hospital
Kara L Cushing-HaugenFred Hutchinson Cancer Center
Sian FeredayPeter MacCallum Cancer Centre, The University of Melbourne
Sian FeredayPeter MacCallum Cancer Centre, The University of Melbourne
Simon A GaytherCenter for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center
Aleksandra Gentry-MaharajMRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London
Aleksandra Gentry-MaharajMRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London
Cyril B GilksUniversity of British Columbia
Mercedes Jimenez-LinanAddenbrooke's Hospital
Catherine J KennedyThe Westmead Institute for Medical Research, Westmead Hospital, Australia The University of Sydney
Anna M PiskorzCancer Research UK Cambridge Institute, University of Cambridge
Naveena SinghBarts Health National Health Service Trust, Vancouver General Hospital
Aline TalhoukUniversity of British Columbia, and Vancouver General Hospital
Martin WidschwendterEUTOPS Institute, University of Innsbruck
David D L BowtellPeter MacCallum Cancer Centre, The University of Melbourne
David D L BowtellPeter MacCallum Cancer Centre, The University of Melbourne
Ren??e T FortnerGerman Cancer Research Center (DKFZ)
Holly R HarrisFred Hutchinson Cancer Center, University of Washington
David G HuntsmanUniversity of British Columbia, BC Cancer Research Centre
David G HuntsmanUniversity of British Columbia, BC Cancer Research Centre
Martin K??belUniversity of Calgary, Foothills Medical Center
Martin K??belUniversity of Calgary, Foothills Medical Center
Usha MenonMRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London
Usha MenonMRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Michael S AnglesioUniversity of British Columbia, and Vancouver General Hospital
Michael S AnglesioUniversity of British Columbia, and Vancouver General Hospital
Malcolm C PikeMemorial Sloan-Kettering Cancer Center, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Malcolm C PikeMemorial Sloan-Kettering Cancer Center, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Anna DeFazioThe University of Sydney, The Westmead Institute for Medical Research, Westmead Hospital, Australia The University of Sydney
Anna DeFazioThe University of Sydney, The Westmead Institute for Medical Research, Westmead Hospital, Australia The University of Sydney
Susan J RamusSchool of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Susan J RamusSchool of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
  • 1 - 41

Datasets